Position in DGX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$274,899
-$107,457 QoQ
Shares Held
1,297
-33.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#766
of 1,095 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $3,275,353 across 4 Diagnostics & Research names. DGX ranks #4 (8.4% of the industry book) .
All Filings in DGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $274,899 | 1,297 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $382,356 | 1,951 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $222,638 | 1,283 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $294,446 | 1,545 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $532,423 | 2,964 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $473,929 | 2,801 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $560,746 | 3,717 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $353,659 | 2,278 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $325,363 | 2,377 | Shares | Sole | 2024-07-18 | |
| 2022-12-31 | $219,016 | 1,400 | Shares | Sole | 2023-01-09 | |
| 2022-03-31 | $202,415 | 1,479 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $563,320 | 3,256 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $512,653 | 3,528 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $555,989 | 4,213 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $206,627 | 1,610 | Shares | Sole | 2021-04-16 | |
| No filing history on record for this holder in this stock. | ||||||